Problems in assessment of new pharmacologic agents for the heart failure patient.
暂无分享,去创建一个
E. Braunwald | W. Grossman | B. Carabello | J. Wynne | W. Colucci | R. Rude | J. Benotti | R. Malacoff
[1] E. J. Brown,et al. Acute Effects of Oral Pirbuterol on Myocardial Oxygen Metabolism and Systemic Hemodynamics in Chronic Congestive Heart Failure , 1981, Circulation.
[2] B. Tandon. A COORDINATED APPROACH TO CHILDREN'S HEALTH IN INDIA INTEGRATED CHILD DEVELOPMENT SERVICE , 1981, The Lancet.
[3] E. Amsterdam,et al. Hemodynamic Effects of Oral Pirbuterol in Chronic Severe Congestive Heart Failure , 1981, Circulation.
[4] E. Braunwald,et al. Effects of amrinone on experimental acute myocardial ischaemic injury. , 1980, Cardiovascular research.
[5] E. Braunwald,et al. Effects of Amrinone on Myocardial Energy Metabolism and Hemodynamics in Patients with Severe Congestive Heart Failure Due to Coronary Artery Disease , 1980, Circulation.
[6] E. Braunwald,et al. Oral amrinone in refractory congestive heart failure. , 1980, The American journal of cardiology.
[7] D. Mason,et al. Comparative effects of oral pirbuterol versus intravenous dobutamine on left ventricular function and energetics in chronic congestive heart failure: Unique advantage of pirbuterol due to vasodilator and inotropic properties , 1980 .
[8] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[9] G. Y. Lesher,et al. Cardiotonic Activity of Amrinone–Win 40680 [5‐Amino‐3,4f‐bipyridin‐6(lH)‐one] , 1979, Circulation research.
[10] L. Benet,et al. Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.
[11] E. Sonnenblick,et al. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.
[12] E. Sonnenblick,et al. Amrinone A New Non-Glycosidic, Non-Adrenergic Cardiotonic Agent Effective in the Treatment of Intractable Myocardial Failure in Man , 1979, Circulation.
[13] J. Franciosa,et al. Immediate Effects of Hydralazine-Isosorbide Dinitrate Combination on Exercise Capacity and Exercise Hemodynamics in Patients with Left Ventricular Failure , 1979, Circulation.
[14] J A Parker,et al. Regional Ejection Fraction A Quantitative Radionuclide Index of Regional Left Ventricular Performance , 1979, Circulation.
[15] W. Aronow,et al. Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.
[16] E. Sonnenblick,et al. Dobutamine: a new synthetic cardioactive sympathetic amine. , 1979, The New England journal of medicine.
[17] E. Braunwald,et al. Hemodynamic assessment of amrinone. A new inotropic agent. , 1978, The New England journal of medicine.
[18] C. Leier,et al. Comparative Systemic and Regional Hemodynamic Effects of Dopamine and Dobutamine in Patients with Cardiomyopathic Heart Failure , 1978, Circulation.
[19] W. Aronow,et al. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure. , 1978, The American journal of medicine.
[20] W. Grossman,et al. Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response. , 1978, The American journal of medicine.
[21] A. Alousi,et al. New cardiotonic agents: a search for digitalis substitute. , 1978, Life sciences.
[22] S. Ayres,et al. Effect of Dopamine on Hemodynamics and Myocardial Metabolism in Shock Following Acute Myocardial Infarction in Man , 1978, Circulation.
[23] E. Braunwald. Vasodilator therapy--a physiologic approach to the treatment of heart failure. , 1977, The New England journal of medicine.
[24] R. Miller,et al. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.
[25] R R Miller,et al. Combined Dopamine and Nitroprusside Therapy in Congestive Heart Failure: Greater Augmentation of Cardiac Performance by Addition of Inotropic Stimulation to Afterload Reduction , 1977, Circulation.
[26] W. Grossman,et al. Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations. , 1977, The Journal of clinical investigation.
[27] B. Massie,et al. Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.
[28] R. Miller,et al. Pharmacological Mechanisms for Left Ventricular Unloading in Clinical Congestive Heart Failure: Differential Effects of Nitropmsside, Phentolamine, and Nitroglycerin on Cardiac Function and Peripheral Circulation , 1976, Circulation research.
[29] R. Russell,et al. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction. , 1976, The American journal of cardiology.
[30] E. Amsterdam,et al. Hemodynamic effects of nitroglycerin in acute myocardial infarction. , 1975, Circulation.
[31] L. I. Goldberg,et al. Dopamine--clinical uses of an endogenous catecholamine. , 1974, The New England journal of medicine.
[32] J. Cohn,et al. IMPROVED LEFT VENTRICULAR FUNCTION DURING NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION , 1972 .
[33] S. Ayres,et al. Effect of Isoproterenol, l‐Norepinephrine, and Intraaortic Counterpulsation on Hemodynamics and Myocardial Metabolism in Shock following Acute Myocardial Infarction , 1972, Circulation.
[34] H. Swan,et al. Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.
[35] E. Braunwald,et al. Control of myocardial oxygen consumption: physiologic and clinical considerations. , 1971, The American journal of cardiology.
[36] J. Covell,et al. Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.
[37] D T Mason,et al. Usefulness and limitations of the rate of rise of intraventricular pressure (dp-dt) in the evaluation of myocardial contractility in man. , 1969, The American journal of cardiology.
[38] J. Mitchell,et al. Hemodynamic determinants of the maximal rate of rise of left ventricular pressure. , 1963, The American journal of physiology.